Zionexa SAS

GE Heathcare and MediView XR, a med-tech company that leverages augmented reality, announced their collaboration to co-develop the OmnifyXR Interventional Suite System. It will combine medical imaging and mixed-reality solutions to assist physicians and their care teams. The collaboration will pair GE's imaging technologies with MediView's augmented reality and surgical navigation expertise to allow physicians to evaluate multiple holographic displays of live imaging in 3D using Microsoft's HoloLens technology. The aim is to help physicians better assess a patient's anatomy, make more informed clinical decisions and allow for remote collaboration by care teams in different locations. OmnifyXR will be designed and manufactured by MediView XR, and will initially launch in the U.S. "We are thrilled to advance our strategic collaboration with GE Healthcare by co-developing and creating the interventional suite of the future –- one that is designed to improve ergonomics, with natural interactions for optimized workflow and facilitates care team collaboration. "The physician is empowered to simultaneously interface with virtual monitors, holographic 3D anatomy and remotely collaborate with colleagues around the world," Mina Fahim, president and CEO of MediView, said in a statement. THE LARGER TREND In 2021 GE announced its plans to spin off its healthcare unit in early 2023 to separate the company into three public companies, of which one was GE Healthcare. In October the company released details about its progress in splitting the company, noting its plans to organize GE Healthcare into four segments: imaging, patient care solutions (which will include monitoring and digital tools), pharmaceutical diagnostics and ultrasound. GE Healthcare acquired surgical visualization company BK Medical for $1.45 billion in 2021. Previously it purchased both Zionexa, a developer of in-vivo biomarkers to guide cancer treatment, and Swedish medical x-ray-imaging startup Prismatic Sensors. In October, the healthcare giant announced its partnership with AMC Health to offer remote patient monitoring technology to patients after they've been discharged from the hospital.

Fast-growing Indiana-based radiopharmaceutical developer and manufacturer appoints leading radiopharmaceutical executive to new leadership role SpectronRx, a leading radiopharmaceutical contract development and manufacturing organization (CDMO), today announced that leading radiopharmaceutical executive Peter Webner has joined the company as Chief Operating Officer (COO). The news comes as the company continues to rapidly scale its operations across the U.S. and into key countries in Europe and Asia. “Peter Webner is a well-respected and dynamic radiopharmaceutical executive joining us at an exciting time, and I’m pleased to welcome him to SpectronRx’s executive leadership team,” said John Zehner, CEO of SpectronRx. “Along with a proven track record of increasing revenue and bringing new products to market, Peter is also a subject matter expert with a deep understanding of our industry. And as we continue to innovate and grow, he will lead initiatives across our business units that drive exceptional results for our partners and patients globally.” Peter Webner brings more than 35 years of nuclear medicine and radiopharmaceutical industry experience to SpectronRx, along with a proven track record of building and leading industry-focused companies through periods of tremendous growth and profitability. Prior to joining SpectronRx, Webner served as General Manager of Breast Oncology US and Global Executive MI Advisor at GE Healthcare. Webner joined GE Healthcare as part of the company’s acquisition of Zionexa, where he served as CEO. A licensed nuclear medicine technologist, Webner has also held key leadership positions in sales, marketing, product development and operations at Zevacor Molecular and Zevacor Pharma, Eastern Isotopes, IBA Molecular, Positron Corporation, NCM and Mt. Sinai Medical Center in New York. Webner holds numerous industry affiliations and certifications and earned his BA in Radiological Health Sciences at Manhattan College. He also completed advanced studies in product development at the Harvard Graduate School of Business. “I am excited and honored to be joining the diverse and talented SpectronRx team at such an incredible time,” said SpectronRx’s new COO, Peter Webner. “As we continue to expand SpectronRx’s manufacturing footprint and extensive capabilities, we will remain steadfastly dedicated to what matters most; our people, our patients and our partners. The important, life-saving radiopharmaceuticals that we develop and manufacture will help physicians to better diagnose and treat many diseases. It is an honor for me to help provide these critical, cutting-edge products to patients who need them.” SpectronRx has more than 100 employees across four locations and provides services to organizations on three continents. The company works with pharmaceutical and healthcare organizations throughout the U.S., in select European countries and in Asia, where it supplies isotopes to Japan. SpectronRx’s domestic operations include four locations, a 36,000 Sq. Ft. facility in South Bend, Indiana, a 60,000 Sq. Ft. facility in Indianapolis and more than 10 acres in Bunker Hill, Indiana, where it will produce Actinium-225 and a new location in Danbury, Connecticut. To learn more, visit SpectronRx.com.

NEW YORK, July 1, 2022 /PRNewswire/ -- The Insight Partners published latest research study on " Diagnostic Imaging Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality (X-Ray, CT, Endoscopy, Ultrasound, MRI, Nuclear Imaging, Mammography, and Others), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Obstetrics and Gynecology, and Others), and End User (Hospital and Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others)", the global diagnostic imaging market size is projected to reach $53.41 Billion by 2028 from $38.03 Billion in 2022; it is expected to grow at a CAGR of 5.8% from 2022 to 2028. Request Sample PDF Brochure of Diagnostic Imaging Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: Diagnostic Imaging Market Report Scope & Strategic Insights: Global Diagnostic Imaging Market: Competitive Landscape and Key Developments Companies operating in the global diagnostic imaging market implement various organic developments that led to dynamic improvements in the market. Numerous organic growth strategies, such as product development, product approval, and product launch, enhance the global diagnostic imaging market growth. Similarly, several companies are implementing various inorganic strategies, such as partnerships, collaborations, mergers, and acquisitions. Inquiry Before Purchase: In June 2022, Stryker announced the opening of its new research and development facility, Stryker's Global Technology Centre (SGTC), at the International Tech Park, Gurgaon. The 150,000-square-foot facility will help accelerate innovation in India and globally and further support the company's mission to make healthcare better. In April 2022, Wipro GE Healthcare announced the launch of its next-generation Revolution Aspire CT (Computed Tomography) scanner. Revolution Aspire is an advanced imaging solution designed and manufactured end-to-end in India, at the newly launched Wipro GE Medical Devices Manufacturing plant, in line with 'Atmanirbhar Bharat' initiative. The CT system is equipped with higher imaging intelligence to improve clinical confidence when diagnosing diseases and anomalies. In May 2021, GE Healthcare acquired Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that help enable personalized healthcare. Cerianna (fluoroestradiol F-18), an FDA-approved PET imaging agent used as an adjunct to biopsy for the detection of oestrogen receptor (ER) positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer, is being scaled up by the company. Have a question? Speak to Research Analyst : In April 2021, RaySearch Laboratories AB and Canon Medical Systems USA, Inc. expanded their partnership to allow RaySearch's US salesforce to sell Canon Medical's Aquilion Large Bore CT and Celesteion PET/CT products. Together, the companies will bring their integrated radiation oncology portfolio to enhance cancer patient care in the US. In March 2022, Fujifilm India Pvt Ltd unveiled a new range of products at the 74th National Annual Conference of IRIA 2022. The latest portfolio consists of a plethora of products offering complete and integrated solutions for diagnostic purposes, including CT, MRI, X-ray, AI, PACS, endoscopy, and ultrasound systems. Global Diagnostic Imaging Market: Segmental Overview Based on modality, the global diagnostic imaging market is segmented into endoscopy, X-ray, ultrasound, MRI, CT, nuclear imaging, mammography, and others. The X-ray segment holds the largest market share in 2022. Moreover, the CT segment is expected to register the highest CAGR during the forecast period. X-ray or radiography is the oldest and most frequently used form of medical imaging. Some X-ray exams use an iodine-based contrast material or barium to improve the visibility of specific organs, blood vessels, tissues, or bone. Continuous technological advancements and product developments, improved funding, and government investments, especially in countries, such as India and China, are expected to contribute to the market growth during the forecast period. For instance, in 2021, OMRON Corporation announced the development of a new VT-X750-V3 system, the world's fastest CT-type X-ray inspection device to date. Also, in June 2021, the Government of India launched X-ray Setu, a free artificial intelligence (AI) based platform to aid doctors with early COVID-19 interventions. Avail Lucrative DISCOUNTS on "Diagnostic Imaging Market" Research Study : Global Diagnostic Imaging Market: Key Insights The diagnostic imaging market growth driven by the rising prevalence of chronic diseases and increasing technological advancements in diagnostic imaging equipment. However, the shortage of skilled professionals and high costs of diagnostic imaging equipment hamper the global market growth. Artificial intelligence helps improve numerous aspects of the healthcare industry, and diagnostic imaging technique is one of the fields that would benefit greatly. Diagnostic imaging equipment manufacturers worldwide are integrating AI into their products. For example, in September 2018, Nvidia announced launching the Nvidia Clara platform, a combination of software and hardware working together in diagnostic imaging equipment. Such ground-breaking technology can address the challenges of medical instruments and process enormous amounts of data generated every second that doctors and scientists can easily interpret. Additionally, in August 2018, Google's DeepMind announced launching an AI system that can quickly detect over 50 eye disorders using routine medical scans. DeepMind's AI assistant for diagnostic imaging can automatically tackle eye-related issues by identifying disease symptoms within seconds and prioritizing patients who seek urgent care. Directly Purchase Premium Copy of Diagnostic Imaging Market Growth Report (2022-2028) at: AI supportive diagnostic imaging equipment play a vital role in diagnosing and classifying cancers. AI plays a pivotal role in the automated recognition of features from sample medical images while performing diagnostic imaging tasks. For example, automated AI applications enhanced clinicians' qualitative potentials, including detection of numerous tumor lesions at a time among patients, prediction of the resultant tumor by referring to the various databases within a short period, translation of phenotypic variations to genotypic, and persistent monitoring of patients. Further, AI generalizes disease imaging techniques with minimal errors resulting in an earlier and more significant diagnosis of diseases. Browse Adjoining Reports: AI in Medical Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Systems, Services and Software); Application (Cardiology, Oncology, Neurology, Gastroenterology, Musculoskeletal, Others); End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers) and Geography Optical Imaging Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product (Imaging Systems, Illumination Systems, Lenses, Software); Application (Ophthalmology, Dentistry, Dermatology, Cardiology, Neurology, Oncology, Other Applications); End User (Hospitals, Diagnostic Imaging Center, Research Laboratories) Medical Imaging Informatics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Digital Radiography, Ultrasound, MRI, CT, Nuclear Imaging, and Mammography), Application (Hospitals, Ambulatory Healthcare Settings, Diagnostics and Imaging Centers, and Others), and Components (Software, Hardware, and Services) Medical Imaging Equipment Services Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Service Type (Equipment Removal And Relocation, Equipment Repair And Maintenance, Refurbished Systems, Technical Training, Software Upgrades); Service Providers (Original Equipment Manufacturers (OEM), Independent Service Organizations); Modality (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, X-Ray and Others); End User (Hospitals, Diagnostic Centers, Others) Mammography Detectors Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Detector Type (Computed Radiography Detectors, Flat Panel Detectors, CMOS Flat Detectors); End User (Hospitals, Diagnostic Centers) and Geography Digital Radiography Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (CR Tech Digital X-Ray System, DR Tech Digital X-Ray System); Application (Dental, Orthopedics, General Surgery, Oncology, Others) Radiopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Product Type (Technetium-99m, Thallium-201, Gallium-67, Iodine-131, Copper-64, and Other), Application (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others) Therapeutic Ultrasound Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (High Intensity Focused Ultrasound, Extracorporeal Shockwave Lithotripsy); Application (Cancer, Gynecology and Obstetrics, Cardiovascular Disorders, Urinary Disorders, Others); End-User (Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Others) and Geography Ultrasound Image Analysis Software Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Standalone Software, Integrated Software); Application (Obstetrics and Gynecology, Radiology, Cardiology, Nephrology and Urology, Oncology, Orthopedic, Dental, Others); By Product (2D Ultrasound Systems, 3D and 4D Ultrasound Systems, Doppler Imaging) Ophthalmic Ultrasound Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (A-Scan, B-Scan, Combined, Pachymeter, Ultrasound biomicroscope); Mobility (Standalone, Portable); End Use (Hospital, Ambulatory research centers, Ophthalmic clinic, Others) and Geography Color Doppler Ultrasound Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Handheld-based, Trolley-based); End user (Hospitals, Clinics, Diagnostic Centers, Others) and Geography Endoscopy Devices Market to 2025 - Global Analysis and Forecasts By Product (Endoscopes, Visualization Systems, Accessories, and Other Endoscopy Devices); Application (Laparoscopy, Gastrointestinal Endoscopy, Arthroscopy, Obstetrics/Gynecology, Urology Endoscopy, Bronchoscopy, and Other Applications); End User (Hospitals, Ambulatory Surgical Centres, Other End Users) and Geography About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. If you have any queries about this report or if you would like further information, please contact us: Contact Person: Sameer Joshi E-mail: [email protected] Phone: +1-646-491-9876 Press Release: Logo: SOURCE The Insight Partners